세계의 출생전·신생아 유전자 검사 시장 규모는 2024년에 67억 달러에 달했습니다. 향후 IMARC Group은 2033년에 173억 달러에 달하며, 2025-2033년의 성장률(CAGR)은 11.04%에 달할 것으로 예측하고 있습니다. 시장 점유율은 첨단 진단·스크리닝 기기에 대한 수요 증가, 의료 산업의 번영, 신생아에서 선천 기형 및 유전자 이상의 유병률 상승 등을 배경으로 꾸준한 성장을 달성하고 있습니다.
주요 시장 성장 촉진요인: 산전-신생아 유전자 검사 수요 증가와 의료 산업의 성장이 산전-신생아 유전자 검사 시장의 성장을 주도하고 있습니다.
주요 시장 동향 : 주요 동향으로는 산전/신생아 치료에서 맞춤형 의료를 위한 유전자 검사의 채택이 확대되고 있습니다. 이는 산전/신생아 유전자 검사 시장 동향에 긍정적인 영향을 미치고 있습니다.
지역별 동향 : 유전자 검사를 받는 임산부 증가로 북미가 산전 및 신생아 유전자 검사 시장 수요를 주도하고 있습니다. 아시아태평양의 산전/신생아 유전자 검사 시장 전망도 성장할 것으로 예상됩니다.
경쟁 구도: Abbott Laboratories와 BGI Group이 산전/신생아 유전자 검사 시장의 매출을 주도하고 있는 기업입니다.
과제와 기회: 도전에는 윤리적, 법적 고려사항이 포함됩니다. 최근 태아 및 신생아 유전자 검사 시장의 비즈니스 기회는 AI와 ML 기술의 통합에 있습니다.
영유아의 높은 유전자 질환 유병률
태내의 태아는 여러 가지 유전 질환에 노출되어 있습니다. 이러한 유전성 질환의 유전 패턴은 재발 가능성과 임신 중 위험도를 결정하는 역할을 합니다. 염색체 이상이 있는 부모, 유전성 질환의 가족력, 유전성 질환을 가진 다른 자녀가 있는 아기는 유전성 질환에 걸릴 확률이 높습니다. 유아는 유전성 질환에 걸릴 확률이 상당히 높습니다. 또한 이러한 질병은 전 세계에서 영아 사망률의 원인이 되고 있습니다. 예를 들어 세계보건기구(WHO)의 예측에 따르면 전 세계에서 790만 명의 아기가 유전자 이상을 가지고 태어날 것으로 예상됩니다. 따라서 영유아의 유전성 질환의 높은 유병률은 태아 및 신생아 유전자 검사 시장 전망을 촉진하고 있습니다.
기술 발전
산전 및 신생아 유전자 검사 시장의 성장은 주로 기술 발전에 기인합니다. 비침습적 산전 검사 및 차세대 시퀀싱과 같은 많은 중요한 발전은 정확성과 향상된 결과를 보장하는 안전 요건을 유지하면서 선별 절차의 품질을 향상시키고 있습니다. 또한 헬스케어 업계는 이러한 기술 혁신을 활용하여 보다 광범위한 유전적 이상을 감지하고 식별할 수 있도록 적극 권장하고 있습니다. 또한 임산부 부모는 태어날 아이의 건강과 안전을 위해 무엇이 최선인지 결정할 수 있게 됩니다. 또한 대폭적인 개선이 이루어짐에 따라 변환의 신뢰성과 신뢰성이 높아졌습니다.
인지도와 수요 증가
산전/신생아 유전자 검사 시장 개요는 산전/신생아 유전자 검사에 대한 인식과 수요가 증가함에 따라 놀라운 확장을 경험하고 있습니다. 최근에는 임산부 부모와 의료 전문가를 포함한 더 많은 사람들이 조기 유전자 검사의 가치를 인식하고 있습니다. 그 결과, 혁신에 대한 시장의 요구가 높아지고 있습니다. 이 혁신을 통해 사람들은 여전히 존재하는 유전자 이상을 알고 아기의 생명에 대한 위험을 줄이기 위해 적시에 예방 조치를 취할 수 있습니다. 임신한 부모는 태어날 아이의 건강과 안전에 대해 최선의 결정을 내릴 수 있습니다. 전 세계 연구자와 투자자들은 그 수요 증가로 인해 검사 서비스에 주목하고 있습니다.
The global prenatal and newborn genetic testing market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.04% during 2025-2033. The market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities in newborn babies.
Major Market Drivers: The increasing demand for prenatal and newborn genetic testing and a growing medical industry are driving the prenatal and newborn genetic testing market growth.
Key Market Trends: Key trends include increasing adoption of genetic testing for personalized medicine in prenatal and newborn care. This is positively impacting the prenatal and newborn genetic testing market trends.
Geographical Trends: North America leads the prenatal and newborn genetic testing market demand due to the growing number of pregnant women undergoing genetic screening. The prenatal and newborn genetic testing market forecast for Asia Pacific is also expected to witness growth.
Competitive Landscape: Abbott Laboratories and BGI Group are some of the prenatal and newborn genetic testing market companies driving the prenatal and newborn genetic testing market revenue.
Challenges and Opportunities: Challenges include ethical and legal considerations. The prenatal and newborn genetic testing market recent opportunities lie in the integration of AI and ML technologies.
High Prevalence of Genetic Diseases in Infants
The fetuses in the womb are affected by several genetic disorders. The inheritance pattern of these genetic illnesses has a role in determining both the chance of recurrence and the risk they pose during pregnancy. Babies that have a parent with a chromosomal anomaly, a family history of genetic disorders, or another kid who has a genetic disease are more likely to have genetic diseases. Infants are significantly more likely to be affected by hereditary disorders. Furthermore, these illnesses are to blame for infant mortality worldwide. For example, the World Health Organization predicted that 7.9 million babies worldwide are born with genetic abnormalities. Therefore, the high prevalence of genetic diseases in infants is driving the prenatal and newborn genetic testing market outlook.
Technological advancements
The growth of the prenatal and newborn genetic testing market report is mostly due to advancements in technology. A number of significant advancements, such as non-invasive prenatal testing and next-generation sequencing, have improved the quality of the screening procedure while maintaining safety requirements that guarantee accuracy and improved outcomes. Furthermore, it is highly recommended that the healthcare industry use these innovations to detect and identify a larger range of genetic abnormalities. It also makes sure that the expectant parents decide what's best for the health and safety of their unborn child. Furthermore, a significant improvement has been made, which raises the transformations' authenticity and dependability.
Increasing awareness and demand
The prenatal and newborn genetic testing market overview has experienced an incredible expansion due to the growing awareness and demand for prenatal and newborn genetic testing. These days, the value of early genetic screening is being recognized by more people, including expectant parents and healthcare professionals. The market's need for innovation has increased as a result of this. By using this innovation, a person can learn about genetic abnormalities that are still present and take timely preventative action to reduce the risk to the lives of the babies. With regard to the health and safety of their unborn child, pregnant parents are capable of making the best decisions. Researchers and investors from all over the world have been drawn to the testing services due to their increasing demand.
Consumables account for the majority of the market share
Consumables like testing kits and reagents are fueling the prenatal and newborn genetic testing market recent developments. These kits are really important for checking if babies have any genetic problems before they're born or right after they're born. Also, new technology is making these tests better and easier to do. As more people want these tests, the market for the supplies needed for them is growing, too. Doctors need these supplies to offer good genetic testing services. So, these supplies are a big part of why prenatal and newborn genetic testing is becoming more popular and helpful for families.
Non-invasive prenatal testing holds the largest share of the industry
NIPT is the best way to check babies before they're born. It doesn't require taking samples from the womb. It depends on simple blood tests from the mother. This method is safer and more comfortable. It offers accurate results in detecting genetic conditions like Down syndrome. It doesn't involve any complications associated with invasive techniques. Due to these benefits, more expecting parents are opting for NIPT. It's the top choice for prenatal testing as it's convenient, safe, and gives reliable results.
Downs syndrome represents the leading market segment
The largest prenatal and newborn genetic testing market recent price is held by Down syndrome testing. An additional copy of chromosome 21 causes this disorder. It is essential for aspiring parents to get tested for Down syndrome in order to plan for any particular care their child may require. The accuracy and accessibility of Down syndrome diagnostics have increased due to technological breakthroughs. Pregnant women are choosing these tests more frequently in order to protect the health of their unborn child. Furthermore, these examinations are advised by medical professionals as standard prenatal care. There is a large demand for testing, which has led to its dominance in the genetic testing market.
Hospital represents the leading market segment
Hospitals are at the top of the market. They are essential in the provision of many medical services, such as genetic testing. Patients seeking genetic testing services prefer hospitals as they are dependable and convenient. Hospitals provide accurate testing and appropriate counselling for patients and their families since they have highly qualified staff and modern facilities. Hospitals also frequently work with medical specialists to provide proper care. People are drawn to hospitals due to their reputation for providing high-quality healthcare services. They thereby lead the market share, confirming their status as the main suppliers of genetic testing services.
North America leads the market, accounting for the largest prenatal and newborn genetic testing market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
With a sizable portion of the global market for prenatal and newborn genetic testing, North America currently has a prominent position. The prenatal and newborn genetic testing market has strengthened its position in the region due to a significant number of companies operating in the diagnostics and screening sectors, in addition to the region's increased prevalence of genetic abnormalities and a huge pool of highly aware parents. Also, an increasing number of expecting mothers in this area are having their genetics screened, which supports the market's expansion. The strong purchasing power and growing public knowledge are anticipated to fuel market expansion. For example, March 21st is designated as World Down Syndrome Day each year to raise awareness of the diagnosis and care of individuals with Down syndrome.
The market for prenatal and newborn genetic testing is expanding rapidly due to the major companies' creativity, innovation, teamwork, and cutting-edge technology. Some of the biggest businesses are constantly working to improve the testing process's quality and safety. The key players are primarily concerned with growing the test panels' capacity to screen for and identify genetic diseases. Additionally, the market for prenatal and newborn genetic testing is expanding at an even faster rate with the help of technological advancements. Furthermore, accessibility and flexibility are guaranteed through partnerships with regulatory bodies and the healthcare industry. Both the expecting parents and their newborns greatly benefit from prenatal and newborn genetic testing.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.